About LUPIN LIMITED
LUPIN LIMITED is a Public Limited Company and was incorporated on Mar 01, 1983 in India. It is registered at Registrar of Companies, ROC Mumbai. Its registered address is Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (, East), Mumbai City, MUMBAI, Maharashtra, India, 400055. Its corporate identification number is (CIN) L24100MH1983PLC029442 and its current status is Active. Its industry classification as per MCA is manufacture Of Basic Chemicals. It had a team size of 2882 employees as on Jan 31, 2025.
LUPIN LIMITED's last Annual General Meeting (AGM) was held on Aug 11, 2025 as per records from Ministry of Corporate Affairs (MCA). LUPIN LIMITED's authorised share capital is ₹200Cr and its paid up capital is ₹91.4Cr. The current board of directors of LUPIN LIMITED comprises Vinita Deshbandhu Gupta, Nilesh Deshbandhu Gupta and 7 more.
LUPIN LIMITED generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for LUPIN LIMITED
- *****@lupin.com, *****@lupin.com
- Registered Address
- Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (, East), Mumbai City, MUMBAI, Maharashtra, India, 400055
Brands associated with LUPIN LIMITED
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
App based patient support program for diabetes management | 2023 | Unfunded | ||
Chain of pathology laboratory centers | 2021 | Unfunded |
Principal Business Activity of LUPIN LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | kdh |
Documents of LUPIN LIMITEDFY 25 Available
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form PAS-3 | Other eForm Documents | Apr 16, 2026 |
List of Allottees | Other eForm Documents | Apr 16, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Apr 16, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Apr 16, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Mar 10, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Mar 10, 2026 |
List of Allottees | Other eForm Documents | Mar 10, 2026 |
Form PAS-3 | Other eForm Documents | Mar 10, 2026 |
Optional attachment(s) - if any | Other eForm Documents | Feb 23, 2026 |
Optional attachment(s)- if any | Other eForm Documents | Feb 23, 2026 |
Financials of LUPIN LIMITEDFY 25 Available
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 8302 | 3501 | 4476 | 1542 | 8823 |
Total Sales | 8721 | 9374 | 1691 | 2768 | 4210 |
Total Expenses | 7397 | 2284 | 8513 | 6017 | 3041 |
Operating Expenses | 8261 | 4262 | 2864 | 6381 | 9718 |
Employee Expenses | 9936 | 6144 | 2565 | 4447 | 4368 |
Marketing Expenses | 3769 | 7556 | 9921 | 2322 | 9474 |
Operating Income (EBIT) | 5450 | 3360 | 9489 | 8455 | 5377 |
Interest Expenses | 5791 | 6114 | 2819 | 6548 | 6602 |
Expenses from other activities | 3993 | 8953 | 4239 | 7039 | 9402 |
EBITDA | 5207 | 2238 | 2675 | 5314 | 4838 |
Taxes | 9905 | 8034 | 4512 | 6374 | 3773 |
Net Profit | 9888 | 3138 | 7644 | 4269 | 9890 |
Balance Sheet | |||||
Assets | 8444 | 1944 | 4856 | 2024 | 5693 |
Cash Equivalent | 7825 | 7629 | 1565 | 8662 | 8581 |
Accounts Receivables | 2267 | 4734 | 7743 | 2535 | 2749 |
Inventory | 5754 | 6695 | 5955 | 7695 | 5658 |
Liabilities | 9097 | 4679 | 6250 | 2062 | 3073 |
Total Debt | 5806 | 1442 | 9630 | 5559 | 6460 |
Accounts Payable | 4793 | 8899 | 4543 | 9451 | 3553 |
Equities | 2218 | 7428 | 4685 | 1944 | 7849 |
Cashflow Statement | |||||
Cash from Operating activities | 9761 | 3405 | 4078 | 8203 | 6605 |
Cash from Investing activities | 4006 | 5418 | 1368 | 4669 | 6563 |
Net cash from Financing activities | 5382 | 1682 | 7936 | 6511 | 9828 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 3942 | 2119 | 5881 | 6843 | 6337 |
EBIT Margin | 2597 | 4315 | 4335 | 5111 | 3763 |
Net Profit Margin | 9353 | 1711 | 4293 | 8424 | 2653 |
Return on Assets (ROA) | 7493 | 5787 | 2352 | 8500 | 1463 |
Return on Equity (ROE) | 1767 | 5969 | 2812 | 5645 | 6071 |
Return on Capital Employed | 6636 | 1169 | 9282 | 8626 | 1051 |
Return on Invested Capital | 9794 | 4555 | 8575 | 7455 | 8455 |
Efficiency Ratios | |||||
Asset Turnover | 8144 | 1285 | 5749 | 2052 | 8435 |
Receivables Turnover | 7859 | 3336 | 6754 | 9085 | 3442 |
Days Sales Outstanding | 9547 | 3650 | 3345 | 5976 | 2181 |
Inventory Turnover | 3936 | 3249 | 8759 | 7059 | 7794 |
Days Inventory Outstanding | 9813 | 1511 | 6212 | 1189 | 9049 |
Payables Turnover | 2858 | 2588 | 1385 | 8076 | 9162 |
Days Payables Outstanding | 6430 | 4907 | 4168 | 6909 | 5470 |
Liquidity Ratios | |||||
Current Ratio | 1653 | 3892 | 1442 | 9240 | 6294 |
Quick Ratio | 7143 | 8853 | 8698 | 7147 | 8865 |
Cash Ratio | 8332 | 1771 | 4245 | 1519 | 3927 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 5451 | 8783 | 7044 | 2357 | 8109 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 4067 | 9338 | 7259 | 9641 | 5284 |
Debt Ratio | 3743 | 9987 | 4364 | 9982 | 5537 |
Net Debt | 3624 | 2041 | 6248 | 9822 | 3023 |
Interest Coverage Ratio | 6081 | 8173 | 6172 | 9775 | 1697 |
Debt Service Coverage Ratio | 9170 | 6368 | 2450 | 6339 | 3683 |
Net Debt/EBITDA | 8047 | 9609 | 1806 | 4136 | 1660 |
Solvency Ratios | |||||
Runway (in months) | 9429 | 2077 | 8950 | 2021 | 4971 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 7989 | 3535 | 4234 | 1611 | 6007 |
Earnings Growth Rate (CAGR) | 1353 | 7892 | 8289 | 8667 | 8314 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of LUPIN LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 14% |
3 Year | 680 |
5 Year | 244 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 39% |
3 Year | 508 |
5 Year | 684 |
MSME Payment Delays by LUPIN LIMITED
Supplier Name | Supplier PAN | Amount Due | Due since |
|---|---|---|---|
As per Annexure Attached :- | 2919 | 2923 | 8114 |
HEALTHP
LIX
TECHNOL
OGIES
PRIVATE
LIM | 4670 | 2854 | 3274 |
PHAROSE
REMEDIE
S
LIMITED | 5248 | 9136 | 6012 |
Onesolut
ion
Advertise
rs pvt Ltd
(na | 3203 | 4378 | 9415 |
BHAVTEJ
SYNTEX (
P) LTD | 8826 | 6940 | 4648 |
GB PACK
PRIVATE
LIMITED | 5127 | 3046 | 3636 |
Centrix
Healthcar
e Limited | 7036 | 9305 | 5926 |
DOCTOR
PACK
INDIA
PVT.LTD | 3325 | 2336 | 1749 |
GLENFIN
CHEMICA
LS PVT.
LTD. | 4992 | 9150 | 4023 |
RAMNIKLAL S GOSALIA& CO | 2647 | 3426 | 5668 |
Loans and Charges on LUPIN LIMITED
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100545697 | ₹100Cr | iudlpno | Feb 18, 2022 | rp{naxw | |
100545484 | ₹200Cr | vmdppgl | Feb 17, 2022 | byhbwjc | |
100523538 | - | ₹50Cr | fu{hblm | Dec 27, 2021 | prldgjr |
10056046 | - | ₹52.1Cr | djfohql | Jun 04, 2007 | bkermwd |
10014370 | - | ₹52.1Cr | hczdsuc | Aug 01, 2006 | gfstrzt |
80036295 | - | ₹23.1Cr | hwtqb{s | Feb 25, 2005 | epqjxdz |
80036252 | - | ₹22.7Cr | gtxjjry | Feb 25, 2005 | ebgbogr |
80031386 | - | ₹13.6Cr | wiedtvs | Oct 20, 2003 | osahabk |
90223480 | - | ₹23L | wczodap | Oct 20, 2003 | dtwizoi |
90223406 | - | ₹20Cr | kftbaof | Dec 23, 2002 | paykk{q |
90220439 | - | ₹15Cr | qugdmdz | Nov 21, 2002 | uujweak |
90226757 | - | ₹15Cr | tudouiz | Nov 21, 2002 | dvpivmq |
90226754 | ₹1,500Cr | aopp{pl | Sep 23, 2002 | bqjdldg | |
90225203 | ₹5Cr | vvwslpx | May 30, 2002 | h{pbxlw | |
90223337 | - | ₹17Cr | joxqrei | Mar 21, 2002 | gmsmcws |
90226749 | ₹10Cr | drwqxdv | Mar 19, 2002 | xssisyx | |
90225186 | ₹360Cr | kedamdw | Feb 21, 2002 | {ksi{ey | |
90223316 | - | ₹20Cr | rsbjdi{ | Jan 18, 2002 | zlbrc{m |
90226373 | - | ₹15Cr | mblnpwd | Dec 13, 2001 | bnksjib |
90225161 | ₹12Cr | nhogsiy | Nov 07, 2001 | kmipicj |
Credit Ratings of LUPIN LIMITED
GSTIN Details of LUPIN LIMITED
Board of Directors and Signatories of LUPIN LIMITED
Board of Directors of LUPIN LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Whole-time Director | Current | Sep 01, 2013 | 12 Years 10 Months | |
Managing Director | Current | Sep 01, 2013 | 12 Years 10 Months | |
Director | Current | Aug 11, 2017 | 8 Years 11 Months | |
Whole-time Director | Current | Aug 12, 2020 | 5 Years 11 Months | |
Director | Current | Mar 17, 2021 | 5 Years 4 Months | |
Director | Current | Mar 17, 2021 | 5 Years 4 Months | |
Director | Current | May 31, 2024 | 2 Years 1 Month | |
Director | Current | May 31, 2024 | 2 Years 1 Month | |
Director | Current | May 30, 2025 | 1 Year 1 Month |
Signatories of LUPIN LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Managing Director | Current | Sep 01, 2013 | 12 Years 10 Months | |
Whole-time Director | Current | Sep 01, 2013 | 12 Years 10 Months | |
Director | Current | Aug 11, 2017 | 8 Years 11 Months | |
Whole-time Director | Current | Aug 12, 2020 | 5 Years 11 Months | |
Director | Current | Mar 17, 2021 | 5 Years 4 Months | |
Director | Current | Mar 17, 2021 | 5 Years 4 Months | |
Director | Current | May 31, 2024 | 2 Years 1 Month | |
Director | Current | May 31, 2024 | 2 Years 1 Month | |
Company Secretary | Current | Sep 03, 2024 | 1 Year 10 Months | |
Director | Current | May 30, 2025 | 1 Year 1 Month |
Cross Directorships of LUPIN LIMITED
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
LUPIN DIAGNOSTICS LIMITED CIN: U24100MH2011PLC214885, India, Active | 590 | 428 | 455 | 166 |
LUPIN BIOLOGICS LIMITED CIN: U24299MH2021PLC354211, India, Active | 515 | 841 | 752 | 289 |
LUPIN MANUFACTURING SOLUTIONS LIMITED CIN: U21001MH2023PLC407210, India, Active | 874 | 850 | 699 | 985 |
LUPIN DIAGNOSTICS LIMITED CIN: U24100MH2011PLC214885, India, Active | 721 | 322 | 923 | 645 |
NOVODIGM LIMITED CIN: U24231GJ2006PLC047462, India, Amalgamated | 480 | 916 | 289 | 730 |
LUPIN DIGITAL HEALTH LIMITED CIN: U74999MH2021PLC360783, India, Active | 825 | 276 | 972 | 185 |
LUPIN INTERNATIONAL PRIVATE LIMITED CIN: U24110MH1988PTC046677, India, Amalgamated | 845 | 322 | 873 | 472 |
Zyma Laboratories Limited CIN: U24230MH1970PLC014881, India, Amalgamated | 544 | 576 | 519 | 100 |
POLYNOVA INDUSTRIES LIMITED CIN: U25209MH1986PLC041294, India, Active | 459 | 682 | 392 | 337 |
ZYMA PROPERTIES PRIVATE LIMITED CIN: U70109MH2017PTC291325, India, Active | 388 | 633 | 343 | 225 |
ELEMENT119 LEASING AND FINANCE PRIVATE LIMITED CIN: U70101MH2013PTC241880, India, Dissolved (Liquidated) | 913 | 310 | 434 | 776 |
LUPIN PROPERTIES LIMITED CIN: U70102MH1995PLC085279, India, Amalgamated | 273 | 280 | 145 | 632 |
LUPIN INVESTMENTS PRIVATE LIMITED CIN: U65990MH1984PTC034012, India, Active | 178 | 841 | 189 | 358 |
RAHAS INVESTMENTS PRIVATE LIMITED CIN: U65990MH1991PTC060087, India, Amalgamated | 783 | 783 | 734 | 576 |
SYNCHEM PROPERTIES PRIVATE LIMITED CIN: U70102MH2015PTC269591, India, Active | 142 | 161 | 413 | 426 |
LUPIN LIFE SCIENCES LIMITED CIN: U86100MH2023PLC406793, India, Active | 351 | 343 | 407 | 727 |
LUPINLIFE CONSUMER HEALTHCARE LIMITED CIN: U21002MH2025PLC443065, India, Active | 315 | 452 | 784 | 886 |
TATA CHEMICALS LIMITED CIN: L24239MH1939PLC002893, India, Active | 826 | 252 | 713 | 115 |
UFO MOVIEZ INDIA LIMITED CIN: L22120MH2004PLC285453, India, Active | 344 | 536 | 415 | 968 |
BHARAT FORGE LTD CIN: L25209PN1961PLC012046, India, Active | 774 | 798 | 549 | 243 |
Legal Cases involving LUPIN LIMITED
Employee Count of LUPIN LIMITED
Date | Employee Count |
|---|---|
Jan 25 | 2882 |
Dec 24 | 820 |
Nov 24 | 337 |
Oct 24 | 787 |
Sep 24 | 407 |
Aug 24 | 489 |
Jul 24 | 391 |
Trademarks of LUPIN LIMITED
Patents of LUPIN LIMITED
Competitors & Alternates of LUPIN LIMITED
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Breathe Well-Being 2015, Delhi (India), Series A | Provider of clinically proven type 2 diabetes management programs | $12.9M | 50/100 | |
2nd | App based patient support program for diabetes management | - | - | 46/100 | |
3rd | Habitual 2019, London (United Kingdom), Seed | Provider of GLP-1 medication and meal replacement weight loss programs. These programs combine medically supervised weight loss medications with meal replacement options and behavioral change support. The company offers various plans tailored to individual needs and preferences, including options focusing on medication or meal replacements. Support includes access to a dedicated team, an app with tracking tools and educational resources, and community features. The goal is to help individuals achieve and maintain weight loss and improve overall health. | $4.04M | 45/100 | |
4th | Online platform to store health records for emergency support | $26.2K | - | 41/100 | |
5th | Freedom from Diabetes 2013, Pune (India), Unfunded | Provider of online diabetes reversal programs and holistic health transformation. It offers various programs, including online and residential options, focusing on lifestyle changes to reverse type 2 diabetes and manage related disorders. These programs combine medical support, dietary guidance, exercise plans, and stress-reduction techniques. The organization also provides ongoing support and education to participants. A key component is personalized care tailored to individual needs. | - | - | 39/100 |
6th | Una Health 2021, Berlin (Germany), Seed | Digital therapy platform for people living with diabetes | $2.5M | 34/100 | |
7th | TGHC Technologies 2020, Bengaluru (India), Unfunded | Provider of science-led health coaching and physician coordination services for chronic lifestyle conditions | - | - | 33/100 |
8th | CIPRA.ai 2022, San Diego (United States), Seed | AI based platform offering personalized and proactive chronic care solutions | $1M | - | 30/100 |
9th | InsuLearn 2023, United States, Unfunded | Developer of algorithms for automated insulin delivery | - | - | 29/100 |
10th | Digital health coach and platform for diabetes management | - | - | 24/100 |